Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 22% ± 4% | |
endothelial cell | 4 studies | 21% ± 2% | |
glutamatergic neuron | 3 studies | 21% ± 2% | |
basal cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 8274.07 | 653 / 653 | 100% | 68.16 | 605 / 605 |
skin | 100% | 6077.08 | 1809 / 1809 | 100% | 56.45 | 471 / 472 |
ovary | 100% | 9318.98 | 180 / 180 | 100% | 48.34 | 429 / 430 |
esophagus | 100% | 8424.80 | 1445 / 1445 | 99% | 31.92 | 182 / 183 |
prostate | 100% | 9218.74 | 245 / 245 | 99% | 44.14 | 499 / 502 |
breast | 100% | 8292.19 | 459 / 459 | 99% | 42.10 | 1111 / 1118 |
uterus | 100% | 10874.54 | 170 / 170 | 99% | 51.92 | 456 / 459 |
brain | 99% | 4813.28 | 2624 / 2642 | 100% | 36.86 | 703 / 705 |
bladder | 100% | 10319.24 | 21 / 21 | 99% | 40.44 | 499 / 504 |
kidney | 100% | 5899.51 | 89 / 89 | 99% | 33.38 | 890 / 901 |
intestine | 100% | 8595.55 | 966 / 966 | 98% | 27.51 | 519 / 527 |
adrenal gland | 100% | 7858.29 | 258 / 258 | 98% | 35.64 | 226 / 230 |
lung | 100% | 7065.28 | 577 / 578 | 98% | 35.20 | 1136 / 1155 |
stomach | 100% | 5743.61 | 359 / 359 | 98% | 27.04 | 279 / 286 |
pancreas | 97% | 2326.34 | 318 / 328 | 99% | 37.58 | 176 / 178 |
liver | 53% | 855.95 | 120 / 226 | 67% | 14.54 | 271 / 406 |
adipose | 100% | 8614.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10441.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 93.98 | 80 / 80 |
spleen | 100% | 5810.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 53.82 | 1 / 1 |
heart | 100% | 4421.98 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 2804.52 | 777 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 17.21 | 26 / 29 |
peripheral blood | 31% | 625.47 | 286 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051013 | Biological process | microtubule severing |
GO_0060682 | Biological process | primary ureteric bud growth |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0051255 | Biological process | spindle midzone assembly |
GO_0051168 | Biological process | nuclear export |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0072197 | Biological process | ureter morphogenesis |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0005813 | Cellular component | centrosome |
GO_0030496 | Cellular component | midbody |
GO_0005829 | Cellular component | cytosol |
GO_0031982 | Cellular component | vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005874 | Cellular component | microtubule |
GO_0005515 | Molecular function | protein binding |
Gene name | LZTS2 |
Protein name | LZTS2 protein Leucine zipper putative tumor suppressor 2 Leucine zipper tumor suppressor 2 Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1) |
Synonyms | LAPSER1 KIAA1813 |
Description | FUNCTION: Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin. . |
Accessions | B1AL11 ENST00000370220.1 ENST00000454422.2 ENST00000481129.1 B1AL13 ENST00000426584.5 ENST00000370223.7 ENST00000429732.5 B1AL12 ENST00000454422.1 Q9BRK4 Q9BRY6 S4R3W7 |